Angiotensin 1/2 (5-7): Precision Peptide for Renin-Angiotensin Research

Executive Summary: Angiotensin 1/2 (5-7) is a biologically active oligopeptide with the sequence H2N-Ile-His-Pro-OH and a molecular formula of C₁₇H₂₇N₅O₄ (APExBIO). It acts as a potent vasoconstrictor, directly increasing blood pressure via the renin-angiotensin system (RAS) (Oliveira et al. 2025). The peptide is formed from angiotensin I by enzymatic cleavage and is soluble at ≥36.5 mg/mL in DMSO, ≥50 mg/mL in ethanol or water. High-purity lots (≥98.36% by HPLC) are available, supporting reproducible research in hypertension and COVID-19 pathogenesis (internal reference).

Biological Rationale

Angiotensin 1/2 (5-7) is a peptide fragment derived from the sequential proteolysis of angiotensinogen, a serum globulin synthesized in the liver (Oliveira et al. 2025). Angiotensinogen is cleaved by renin to form angiotensin I (1–10), which is further processed by angiotensin-converting enzyme (ACE) to yield angiotensin II (1–8). N-terminal truncation of angiotensin II produces shorter bioactive peptides such as angiotensin 1/2 (5-7), with the sequence H2N-Ile-His-Pro-OH. These peptides participate in the RAS cascade, a central regulator of blood pressure, vascular tone, and fluid homeostasis. Angiotensin 1/2 (5-7) retains vasoconstrictor and dipsogenic activity, making it relevant to both cardiovascular and renal research. Its role in augmenting peptide-mediated signaling has made it a model system for studying hypertension, peptide hormone action, and viral pathogenesis, particularly in the context of SARS-CoV-2 spike protein–host receptor interactions (internal review).

Mechanism of Action of Angiotensin 1/2 (5-7)

The H2N-Ile-His-Pro-OH peptide (Angiotensin 1/2 (5-7)) exerts its effects primarily through vasoconstriction and dipsogenic signaling. It acts downstream of the classical RAS pathway. While angiotensin I is biologically inactive, angiotensin 1/2 (5-7) demonstrates potent activity by binding to G protein–coupled receptors (notably AT1R and AT2R) on vascular smooth muscle cells. This binding results in increased intracellular calcium, smooth muscle contraction, and subsequent elevation of systemic blood pressure. The peptide also exhibits dipsogenic properties, stimulating thirst and sodium appetite. Recent studies indicate that truncated angiotensin peptides, including 1/2 (5-7), enhance SARS-CoV-2 spike protein binding to AXL and potentially ACE2, suggesting an intersection between cardiovascular regulation and viral pathogenesis (Oliveira et al. 2025). Modifications to the peptide, such as tyrosine residue phosphorylation or substitution, further modulate this interaction.

Evidence & Benchmarks

• Angiotensin 1/2 (5-7) is a potent vasoconstrictor, rapidly increasing blood pressure in vivo (Oliveira et al. 2025, DOI).
• The peptide sequence H2N-Ile-His-Pro-OH is derived from the N-terminal truncation of angiotensin II (1–8) (Oliveira et al. 2025, DOI).
• Solubility is validated at ≥36.5 mg/mL in DMSO, ≥50 mg/mL in ethanol, and ≥50 mg/mL in water at ambient temperature (APExBIO product page).
• High-purity lots (≥98.36% by HPLC) and mass spectrometry–confirmed identity ensure experimental reproducibility (APExBIO).
• Angiotensin 1/2 (5-7) enhances SARS-CoV-2 spike protein binding to AXL by a measurable fold increase compared to longer peptides (Oliveira et al. 2025, Figure 2, DOI).
• Internal benchmarking confirms workflow reliability in blood pressure and viral pathogenesis assays (internal article).

Applications, Limits & Misconceptions

Angiotensin 1/2 (5-7) is used in cardiovascular, renal, and viral pathogenesis research. Its validated activity in vasoconstriction and RAS signaling makes it ideal for hypertension, dipsogenesis, and receptor-binding studies. The peptide is also a tool in exploring SARS-CoV-2–host interactions, particularly spike protein binding enhancement. APExBIO’s formulation (A1049) is supplied as a solid, stored at -20°C, and should be used promptly after solution preparation to preserve integrity (product page).

Common Pitfalls or Misconceptions

• Angiotensin 1/2 (5-7) is not biologically inert; it exhibits vasoconstrictor and dipsogenic effects, unlike angiotensin I.
• Long-term storage of solutions is not recommended; peptide should be prepared fresh for each experiment.
• The peptide's activity is sequence-specific; substitutions or modifications may alter biological outcomes.
• Solubility claims apply to pure peptide; presence of buffers or excipients can affect dissolution.
• While potent in blood pressure models, its role in direct viral inhibition is not established; enhancement of viral spike binding is a mechanistic observation, not a therapeutic claim (DOI).

For a deeper dive into the peptide’s role in translational research, see this mechanistic overview, which is extended here with new SARS-CoV-2 insights. Additionally, this article clarifies the product's experimental solubility and workflow integration, building on scenario-driven solutions discussed in Scenario-Driven Laboratory Solutions.

Workflow Integration & Parameters

Angiotensin 1/2 (5-7) is supplied as a solid by APExBIO (SKU A1049) and should be stored at -20°C. For experimental use, dissolve the peptide to ≥36.5 mg/mL in DMSO, or ≥50 mg/mL in ethanol or water, at room temperature. Avoid repeated freeze–thaw cycles and prepare solutions fresh before each use. Purity is confirmed by HPLC (≥98.36%) and mass spectrometry. The product is validated for applications in blood pressure modulation, cell viability, and viral receptor-binding assays (internal scenario-driven guidance). Shipping is under blue ice for stability.

Conclusion & Outlook

Angiotensin 1/2 (5-7) stands as a benchmark tool for renin-angiotensin system and viral pathogenesis research due to its rigorously validated activity and solubility profile. APExBIO’s high-purity, well-characterized peptide enables reproducible workflows across cardiovascular and infectious disease models. Ongoing research into angiotensin fragments and their interactions with viral proteins highlights the evolving utility of this peptide in basic and translational science. For additional technical data or to order, visit the Angiotensin 1/2 (5-7) product page.